Articles with "receptor modulators" as a keyword



Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS

Sign Up to like & get
recommendations!
Published in 2025 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2025.41025

Abstract: Key Points Question How does cladribine compare with sphingosine-1-phosphate receptor modulators (S1PRMs) in treatment-naive patients with relapsing-remitting multiple sclerosis? Findings In this comparative effectiveness research study of 950 propensity score–matched treatment-naive patients with at least… read more here.

Keywords: treatment; cladribine; relapsing remitting; comparative effectiveness ... See more keywords

Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review

Sign Up to like & get
recommendations!
Published in 2024 at "Annals of Clinical and Translational Neurology"

DOI: 10.1002/acn3.52017

Abstract: Four sphingosine 1‐phosphate (S1P) receptor modulators (fingolimod, ozanimod, ponesimod, and siponimod) are approved by the US Food and Drug Administration for the treatment of multiple sclerosis. This review summarizes efficacy and safety data on these… read more here.

Keywords: receptor; treatment; multiple sclerosis; sphingosine phosphate ... See more keywords

The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials

Sign Up to like & get
recommendations!
Published in 2025 at "Annals of Clinical and Translational Neurology"

DOI: 10.1002/acn3.70122

Abstract: Sphingosine‐1‐phosphate receptor modulators (S1PRM) are used to treat relapsing multiple sclerosis (MS). Each drug has a different S1PR‐subtype selectivity. They target the G‐protein coupled S1P receptors and exert significant immunomodulatory effects, such as preventing the… read more here.

Keywords: sphingosine phosphate; receptor modulators; phosphate receptor; multiple sclerosis ... See more keywords

Synthesis, insecticidal evaluation and 3D-QSAR study of novel anthranilic diamide derivatives as potential ryanodine receptor modulators.

Sign Up to like & get
recommendations!
Published in 2019 at "Pest management science"

DOI: 10.1002/ps.5213

Abstract: BACKGROUND Anthranilic diamide insecticides control lepidopteran pests through selectively binding and activating insect ryanodine receptors. In order to search for potential insecticides targeting the ryanodine receptors, a series of anthranilic diamide analogs including trifluoromethyl, nitro,… read more here.

Keywords: anthranilic diamide; ryanodine receptor; activity; receptor modulators ... See more keywords

Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study

Sign Up to like & get
recommendations!
Published in 2025 at "Journal of Neurology"

DOI: 10.1007/s00415-025-13300-z

Abstract: Sphingosine-1-phosphate (S1P) receptor modulators, regulating the S1P/S1PR pathway, lead to lymphocyte sequestration in lymphoid organs, which results in peripheral lymphopenia. This study evaluates the degree of lymphopenia induced by S1P modulators in people with Multiple… read more here.

Keywords: s1p receptor; lymphopenia; siponimod; receptor modulators ... See more keywords

Benefit–Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis

Sign Up to like & get
recommendations!
Published in 2017 at "Drugs"

DOI: 10.1007/s40265-017-0814-1

Abstract: Since the approval of fingolimod, several selective sphingosine-1-phosphate receptor modulators have entered clinical development for multiple sclerosis. However, side effects can occur with sphingosine-1-phosphate receptor modulators. By considering short-term data across the drug class and… read more here.

Keywords: sphingosine phosphate; phosphate receptor; term; receptor modulators ... See more keywords

Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data

Sign Up to like & get
recommendations!
Published in 2025 at "Pharmacological Reports"

DOI: 10.1007/s43440-025-00725-6

Abstract: The treatment landscape for Multiple Sclerosis (MS) has increased significantly over the past few decades, thanks to the introduction of disease-modifying therapies (DMTs). Fingolimod, siponimod, ozanimod, and ponesimod belong to the newer generation of oral… read more here.

Keywords: multiple sclerosis; lymphopenia; sphingosine phosphate; modulators s1prms ... See more keywords

Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).

Sign Up to like & get
recommendations!
Published in 2022 at "European journal of medicinal chemistry"

DOI: 10.1016/j.ejmech.2022.114119

Abstract: Osteoporosis is a common disease in which the risk of fracture increases due to decreased bone mass and qualitative skeletal changes. Selective androgen receptor modulators (SARMs) are agonists with tissue selectivity, which act as partial… read more here.

Keywords: osteoporosis; androgen receptor; receptor modulators; selective androgen ... See more keywords

Screening Estrogen Receptor Modulators in a Paper-Based Breast Cancer Model.

Sign Up to like & get
recommendations!
Published in 2018 at "Analytical chemistry"

DOI: 10.1021/acs.analchem.8b02486

Abstract: The health risks associated with acute and prolonged exposure to estrogen receptor (ER) modulators has led to a concerted effort to identify and prioritize potential disruptors present in the environment. ER agonists and antagonists are… read more here.

Keywords: paper based; paper; receptor modulators; model ... See more keywords

In-Sewer Stability Assessment of Anabolic Steroids and Selective Androgen Receptor Modulators.

Sign Up to like & get
recommendations!
Published in 2022 at "Environmental science & technology"

DOI: 10.1021/acs.est.1c03047

Abstract: Wastewater-based epidemiology is a potential complementary technique for monitoring the use of performance- and image-enhancing drugs (PIEDs), such as anabolic steroids and selective androgen receptor modulators (SARMs), within the general population. Assessing in-sewer transformation and… read more here.

Keywords: receptor modulators; selective androgen; androgen receptor; steroids selective ... See more keywords

Design and Development of Glucocorticoid Receptor Modulators as Immunology Antibody-Drug Conjugate Payloads.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.1c02099

Abstract: Glucocorticoid receptor modulators (GRM) are the first-line treatment for many immune diseases, but unwanted side effects restrict chronic dosing. However, targeted delivery of a GRM payload via an immunology antibody-drug conjugate (iADC) may deliver significant… read more here.

Keywords: drug conjugate; glucocorticoid receptor; receptor modulators; antibody drug ... See more keywords